V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression

This publication has 22 references indexed in Scilit:

• SIGNIFICANCE OF THE CAG REPEAT POLYMORPHISM OF THE ANDROGEN RECEPTOR GENE IN PROSTATE CANCER PROGRESSION
  Journal of Urology, 2000
• CANCER RECURRENCE AND SURVIVAL RATES AFTER ANATOMIC RADICAL RETROPUBIC PROSTATECTOMY FOR PROSTATE CANCER
  Journal of Urology, 1998
• Effect of the dual 5α-reductase inhibitor Pnu 157706 on the growth of dunning R3327 prostatic carcinoma in the rat
  The Journal of Steroid Biochemistry and Molecular Biology, 1998
• Differential Gene Expression of Steroid 5 -Reductase 2 in Core Needle Biopsies from Malignant and Benign Prostatic Tissue
  Journal of Clinical Endocrinology & Metabolism, 1997
• Prospective Study of Sex Hormone Levels and Risk of Prostate Cancer
  JNCI Journal of the National Cancer Institute, 1996
• Information on death certificates: cause for concern?
  Journal of Clinical Pathology, 1996
• Genetic linkage mapping of the human steroid 5α-reductase type 2 gene (SRD5A2) close to D2S352 on chromosome region 2p23→p22
  Cytogenetic and Genome Research, 1996
• Natural Mutagenesis Study of the Human Steroid 5.alpha.-Reductase 2 Isoenzyme
  Biochemistry, 1994
• Response of rat and human prostatic cancers to the novel 5α‐reductase inhibitor, SK&F 105657
  The Prostate, 1992
• Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer
  New England Journal of Medicine, 1991